8-[4-[2-(1,2,3,4-tetrahydroisoquinolinyl)]butyl]-8-azaspiro[4.5]decane-7,9- dione: A new 5-HT1A receptor ligand with the same activity profile as buspirone

Journal of Medicinal Chemistry

Volumn 39, Issue 5, 1996, Pages 1125-1129

  Mokrosz, Jerzy L ^a   Dereń Wesołek, Anna ^b   Tatarczyńska, Ewa ^b   Duszyńska, Beata ^a   Bojarski, Andrzej J ^a   Mokrosz, Maria J ^a   Chojnacka Wójcik, Ewa ^b  

^a POLISH ACADEMY OF SCIENCES   (Poland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

8 [4 [2 (1,2,3,4 TETRAHYDROISOQUINOLINYL)]BUTYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; BUSPIRONE; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANXIETY NEUROSIS; ARTICLE; DRUG SYNTHESIS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BEHAVIOR, ANIMAL; BUSPIRONE; HIPPOCAMPUS; LIGANDS; MALE; MOLECULAR STRUCTURE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; RESERPINE; SEROTONIN AGONISTS; TETRAHYDROISOQUINOLINES;

EID: 0029898091     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950662c     Document Type: Article

References (36)

1. Goa, K.; Ward, A. Buspirone - a preliminary review on its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs 1986, 32, 114-129.
2. 1A selective drugs on the 5-HT behavioral syndrome. Pharmacol. Biochem. Behav. 1986, 24, 1513-1519.
3. Andrade, R.: Nicoll, R. A. Novel anxiolytics discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampus. Naunyn Schmiedeberg's Arch. Pharmacol. 1987, 356, 5-10.
4. 1A Receptor-related anxiolytics. Trends Pharmacol. Sci. 1987, 8, 432-437.
5. Przegaliński, E.; Tatarczyńska, E.; Chojnacka-Wójcik, E. Anti-conflict effect of ipsapirone, buspirone and gepirone is not mediated by their common metabolite 1-(2-pyrimidinyl)piperazine. J. Psychopharmacol. 1989, 3, 180-185.
6. 1A receptors induces lower lip retraction in the rat. Pharmacol. Biochem. Behav. 1989, 33, 821-827.
7. Przegaliński, E.; Tatarczyńska, E.; Chojnacka-Wójcik, E. Anti-depressant-like activity of ipsapirone, buspirone and gepirone in the forced swimming test in rats pretreated with proadifen. J. Psychopharmacol. 1990, 4, 204-209.
8. New, J. S. The discovery and development of buspirone: a new approach to the treatment of anxiety. Med. Res. Rev. 1990, 10, 283-326.
9. 1A agonists correlates with dopamine antagonist properties. J. Pharmacol. Exp. Ther. 1994, 268, 1297-1303.
10. Zifa, E.; Fillion, E. 5-Hydroxytryptamine receptors. Pharmacol. Rev. 1992, 44, 401-458.
11. Van Wijngaarden, I.; Tulp, M. T. M.; Soudijn, W. The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol.-Mol. Pharmacol. Sect. 1990, 188, 301-312.
12. 2 receptors in the central regulation of the cardiovascular system. Pharmacol. Rev. 1994, 46, 231-243.
13. 1A receptor. 1. The molecular structure of buspirone and its two analogues. J. Med. Chem. 1995, 38, 1701-1710.
14. Glennon, R. A.; Westkaemper, R. B.; Bartyzel, P. In Serotonin Receptor Subtypes: Basic and Clinical Aspects; Peroutka, S. J., Ed.; Wiley-Liss: New York, 1991; pp 19-64.
15. 1A serotorun agonists and antagonists. Drug Dev. Res. 1992, 26, 251-274.
16. Glennon, R. A.; Dukat, M. 5-HT receptor ligands-update 1992. Curr. Drugs: Serotonin. 1992, 1-45
17. 1A serotonin ligands. J. Med. Chem. 1988, 31, 1968-1971.
18. 1A receptor. J. Med. Chem. 1988, 31, 1087-1093.
19. 1A receptor agonists and definition of a steric model of this site. Eur. J. Med. Chem. 1989, 24, 31-37.
20. 1A receptor ligands. 2. Heterobicyclic phenylpiperazines with N4-aralkyl substituents. J. Med. Chem. 1994, 37, 2761-2773.
21. 1A receptors. Bioorg. Med. Chem. 1995, 3, 533-538.
22. 1A ligands. Pharmazie 1994, 49, 781-782.
23. 1A receptors. Arch. Pharm. (Weinheim) 1995, 328, 604-608.
24. Bojarski, A. J.; Mokrosz, M. J.; Paluchowska, M. H. Ionization constants of the model N-alkyl substituted cyclic amines. Pharmazie 1995, 50, 560-570.
25. Caccia, S.; Fong, M. H.; Urso, R Ionization constants and partition coefficients of 1-arylpiperazine derivatives. J. Pharm. Pharmacol. 1985, 37, 567-570.
26. 1A receptor in rat and guineas pig hippocampal membranes. Eur. J. Pharmacol. 1987, 137, 293-294.
27. 1A receptors. Med. Chem. Res. 1994, 4, 161-169.
28. Berendsen, H. H. G.; Broekkamp, C. L. E.; Van Delft, A. M. L. Antagonism of 8-OH-DPAT-induced behaviour in rats. Eur. J. Pharmacol. 1990, 187, 97-103.
29. Cassutti, P.; Carugo, A.; McArthur, R. A. Serotoninergic behavioural effects induced by intrahippocampal infusion of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat. Pharmacol. Res. 1995, 31 (Suppl.), 269.
30. 1 receptor and catecholaminergic system in the behavioural response to 8-hydroxy-2-(di-n-propylamino)-tetralin in the rat. Eur. J. Pharmacol. 1985, 106, 271-282.
31. 2 receptor affinities of 4-alkyl-l-arylpiperazines and their analogs. Arch. Pharm. (Weinheim) 1995, 328, 143-148.
32. 1A receptors. Arch. Pharm. (Weinheim) 1995, 328, 381-383.
33. 1-adrenergic activity. J. Med. Chem. 1991, 34, 2633-2638.
34. 1-adrenergic activity. Synthesis and structure-affinity relationships. J. Med. Chem. 1995, 38, 1273-1277.
35. Wu, Y.-H.; Smith, K. R.; Rayburn, J. W.; Kissel, J. W. Psychosedative agents. N-(4-Phenyl-1-piperazinylalkyl)-substituted cyclic imides. J. Med. Chem. 1969, 12, 876-881.
36. 2 receptor affinity of some 2- and 3-substituted 1,2,3,4-tetrahydro-β-carbolines. Pharmazie 1993, 48, 289-294.